The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
Open accessAbstract
Interleukin-6 (IL-6) is a pleiotropic pro-inflammatory cytokine. Its deregulation is associated with chronic inflammation, and multifactorial auto-immune disorders. It mediates its biological roles through a hexameric complex composed of IL-6 itself, its receptor IL-6R, and glycoprotein 130 (IL-6/IL-6R/gp130). This complex, in turn, activates different signaling mechanisms (classical and trans-signaling) to execute various biochemical functions. The trans-signaling mechanism activates various pathological routes, like JAK/STAT3, Ras/MAPK, PI3K-PKB/Akt, and regulation of CD4+ T cells and VEGF levels, which cause cancer, multiple sclerosis, rheumatoid arthritis, anemia, inflammatory bowel disease, Crohn's disease, and Alzheimer's disease. Involvement of IL-6 in pathophysiology of these complex diseases makes it an important target for the treatment of these diseases. Though some anti-IL-6 monoclonal antibodies are being used clinically, but their high cost, only parenteral administration, and possibility of immunogenicity have limited their use, and warranted the development of novel small non-peptide molecules as IL-6 inhibitors. In the present report, all molecules reported in literature as IL-6 inhibitors have been classified as IL-6 production, IL-6R, and IL-6 signaling inhibitors. Reports available till date are critically studied to identify important and salient structural features common in these molecules. These analyses would assist medicinal chemists to design novel and potent IL-6 production and signaling inhibitors, through knowledge- and/or computer-based approaches, for the treatment of complex multifactorial diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
LPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,304
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 825
IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation
Kaplanski, G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00013-3 · Cited by 811
IL-6 in autoimmune disease and chronic inflammatory proliferative disease
Ishihara, K., & Hirano, T. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00027-8 · Cited by 807
Ikebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y., & Ogawa, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9035 · Cited by 802
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749
Van Snick, J., Cayphas, S., Vink, A., Uyttenhove, C., Coulie, P. G., Rubira, M. R., & Simpson, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9679 · Cited by 680
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K. H., & Kishimoto, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5490 · Cited by 677
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
Rincon, M., & Irvin, C. G. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4874 · Cited by 621
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581
Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 578
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Lai, K.-B., Lee, C.-N., & Hsieh, C.-Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206226 · Cited by 536
Ryan, G. B., & Majno, G. (1977) · PubMed · Cited by 516
Interleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose-John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 509
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Interleukin‐6: A Cytokine for Gerontolgists
Ershler, W. B. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02054.x · Cited by 469
Quintanilla, R. A., Orellana, D. I., González-Billault, C., & Maccioni, R. B. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.01.002 · Cited by 455
Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance
Mudter, J., & Neurath, M. F. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20148 · Cited by 436
Celli, B. R., Locantore, N., Yates, J., Tal-Singer, R., Miller, B. E., Bakke, P., Calverley, P., Coxson, H., Crim, C., Edwards, L. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201110-1792oc · Cited by 432
Interleukin 6 is involved in interleukin 1‐induced activities
Helle, M., Brakenhoff, J. P. J., Groot, E. R. D., & Aarden, L. A. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180619 · Cited by 409
STAT3 SIGNALING: Anticancer Strategies and Challenges
Johnston, P. A., & Grandis, J. R. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.4 · Cited by 406
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller-Newen, G., Grötzinger, J., Rose-John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 400
Nakahara, H., Song, J., Sugimoto, M., Hagihara, K., Kishimoto, T., Yoshizaki, K., & Nishimoto, N. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11143 · Cited by 395
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Bousoik, E., & Montazeri Aliabadi, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00287 · Cited by 376
B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.
Takai, Y., Wong, G. G., Clark, S. C., Burakoff, S. J., & Herrmann, S. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.2.508 · Cited by 366
The role of intratumoral and systemic IL-6 in breast cancer
Dethlefsen, C., Højfeldt, G., & Hojman, P. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2488-z · Cited by 363
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 349
Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
HAEGEMAN, G., CONTENT, J., VOLCKAERT, G., DERYNCK, R., TAVERNIER, J., & FIERS, W. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09931.x · Cited by 337
Somers, W. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.989 · Cited by 335
Weissenbach, J., Chernajovsky, Y., Zeevi, M., Shulman, L., Soreq, H., Nir, U., Wallach, D., Perricaudet, M., Tiollais, P., & Revel, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7152 · Cited by 335
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., Ghalamfarsa, G., Azizi, G., Yousefi, M., & Jadidi-Niaragh, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.177 · Cited by 303
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Regulation of the Acute Phase Response by Cytokines
Kushner, I. (1993) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1993.0004 · Cited by 292
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Chalaris, A., Garbers, C., Rabe, B., Rose-John, S., & Scheller, J. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.007 · Cited by 289
Hama, T., Miyamoto, M., Tsukui, H., Nishio, C., & Hatanaka, H. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90600-9 · Cited by 252
Circulating interleukin-6 levels in patients with bronchial asthma.
Yokoyama, A., Kohno, N., Fujino, S., Hamada, H., Inoue, Y., Fujioka, S., Ishida, S., & Hiwada, K. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735584 · Cited by 248
Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Campbell, I. L., Erta, M., Lim, S. L., Frausto, R., May, U., Rose-John, S., Scheller, J., & Hidalgo, J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-13.2014 · Cited by 247
IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
Unver, N., & McAllister, F. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.04.004 · Cited by 238
Molecular cloning and expression of hybridoma growth factor in Escherichia coli.
Brakenhoff, J. P. J., de Groot, E. R., Evers, R. F., Pannekoek, H., & Aarden, L. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4116 · Cited by 229
Evaluation and Discovery of Novel Synthetic Chalcone Derivatives as Anti-Inflammatory Agents
Wu, J., Li, J., Cai, Y., Pan, Y., Ye, F., Zhang, Y., Zhao, Y., Yang, S., Li, X., & Liang, G. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200946h · Cited by 222
New Concepts in the Pathophysiology of Inflammatory Bowel Disease
Bamias, G., Nyce, M. R., De La Rue, S. A., & Cominelli, F. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00007 · Cited by 221
Zhao, N., Zhang, A.-S., & Enns, C. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67225 · Cited by 209
Dijkgraaf, E. M., Santegoets, S. J. A. M., Reyners, A. K. L., Goedemans, R., Wouters, M. C. A., Kenter, G. G., van Erkel, A. R., van Poelgeest, M. I. E., Nijman, H. W., van der Hoeven, J. J. M., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv309 · Cited by 197
Chang, C. H., Hsiao, C. F., Yeh, Y. M., Chang, G. C., Tsai, Y. H., Chen, Y. M., Huang, M. S., Chen, H. L., Li, Y. J., Yang, P. C., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27892 · Cited by 189
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Molecular and cellular biology of interleukin-6 and its receptor
Keller, E. T. (1996) · Frontiers in Bioscience · doi:10.2741/a136 · Cited by 182
Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314562 · Cited by 181
Qi, F., Inagaki, Y., Gao, B., Cui, X., Xu, H., Kokudo, N., Li, A., & Tang, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01900.x · Cited by 174
Tabibzadeh, S., Kong, Q. F., Babaknia, A., & May, L. T. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135793 · Cited by 173
Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
Culig, Z., & Puhr, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.033 · Cited by 170
Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
Briso, E. M., Dienz, O., & Rincon, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7102 · Cited by 165
Li, H., Xiao, H., Lin, L., Jou, D., Kumari, V., Lin, J., & Li, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401144z · Cited by 161
Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6
Miyaura, C., Kusano, K., Masuzawa, T., Chaki, O., Onoe, Y., Aoyagi, M., Sasaki, T., Tamura, T., Koishihara, Y., Ohsugi, Y., et al. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100914 · Cited by 160
Yang, X.-M., Wang, Y.-S., Zhang, J., Li, Y., Xu, J.-F., Zhu, J., Zhao, W., Chu, D.-K., & Wiedemann, P. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2591 · Cited by 158
IFN-beta2/IL-6 augments the activity of human natural killer cells.
Luger, T., Krutmann, J., Kirnbauer, R., Urbanski, A., Schwarz, T., Klappacher, G., Köck, A., Micksche, M., Malejczyk, J., Schauer, E., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1206 · Cited by 150
Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Miguel, J. F. S., Bladé, J., Shpilberg, O., Grosicki, S., Maloisel, F., Min, C., Zarzuela, M. P., Robak, T., Prasad, S. V. S. S., Goh, Y. T., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546374 · Cited by 148
Kinetics of changes in peritoneal cell populations following acute inflammation
Melnicoff, M. J., Horan, P. K., & Morahan, P. S. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90367-5 · Cited by 147
Interleukin-6 is elevated in plasma in multiple sclerosis
Krei, K., Fredrikson, S., Fontana, A., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90020-8 · Cited by 145
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
Rubbert‐Roth, A., Furst, D. E., Nebesky, J. M., Jin, A., & Berber, E. (2018) · Rheumatology and Therapy · doi:10.1007/s40744-018-0102-x · Cited by 145
Nordan, R. P., Pumphrey, J. G., & Rudikoff, S. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.3.813 · Cited by 144
Smolen, J. S., Weinblatt, M. E., Sheng, S., Zhuang, Y., & Hsu, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205137 · Cited by 139
Structure of the extracellular domains of the human interleukin-6 receptor α-chain
Varghese, J. N., Moritz, R. L., Lou, M., van Donkelaar, A., Ji, H. L., Ivancic, N., Branson, K., Hall, N. E., & Simpson, R. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232432399 · Cited by 138
Associations of IL6 polymorphisms with lung function decline and COPD
He, J., Foreman, M. G., Shumansky, K., Zhang, X., Akhabir, L., Sin, D. D., Man, S. F. P., DeMeo, D. L., Litonjua, A. A., Silverman, E. K., et al. (2009) · Thorax · doi:10.1136/thx.2008.111278 · Cited by 138
Katsume, A., Saito, H., Yamada, Y., Yorozu, K., Ueda, O., Akamatsu, K.-I., Nishimoto, N., Kishimoto, T., Yoshizaki, K., & Ohsugi, Y. (2002) · Cytokine · doi:10.1006/cyto.2002.2012 · Cited by 134
Quintana, A., Müller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J. C., Hidalgo, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900242 · Cited by 130
PTEN and p53: Who will get the upper hand?
Trotman, L. C., & Pandolfi, P. P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00022-9 · Cited by 129
Rovin, B. H., van Vollenhoven, R., Aranow, C. B., Wagner, C. L., Gordon, R. M., Zhuang, Y., Belkowski, S. M., & Hsu, B. L. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39722 · Cited by 129
Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils.
Doherty, D. E., Downey, G. P., Worthen, G. S., Haslett, C., & Henson, P. M. (1988) · PubMed · Cited by 128
Sieper, J., Braun, J., Kay, J., Badalamenti, S., Radin, A. R., Jiao, L., Fiore, S., Momtahen, T., Yancopoulos, G. D., Stahl, N., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204963 · Cited by 127
Content, J., Wit, L. D., Piérard, D., Derynck, R., Clercq, E. D., & Fiers, W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.2768 · Cited by 123
Takatsuki, F., Okano, A., Suzuki, C., Chieda, R., Takahara, Y., Hirano, T., Kishimoto, T., Hamuro, J., & Akiyama, Y. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.9.3072 · Cited by 110
Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
Miura, T., Mitsunaga, S., Ikeda, M., Shimizu, S., Ohno, I., Takahashi, H., Furuse, J., Inagaki, M., Higashi, S., Kato, H., et al. (2015) · Pancreas · doi:10.1097/mpa.0000000000000335 · Cited by 109
Crystal Structure of the Entire Ectodomain of gp130
Xu, Y., Kershaw, N. J., Luo, C. S., Soo, P., Pocock, M. J., Czabotar, P. E., Hilton, D. J., Nicola, N. A., Garrett, T., & Zhang, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.129502 · Cited by 100
Weinblatt, M. E., Mease, P., Mysler, E., Takeuchi, T., Drescher, E., Berman, A., Xing, J., Zilberstein, M., Banerjee, S., & Emery, P. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39249 · Cited by 98
Mihara, M., Kotoh, M., Nishimoto, N., Oda, Y., Kumagai, E., Takagi, N., Tsunemi, K., Ohsugi, Y., Kishimoto, T., Yoshizaki, K., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4989 · Cited by 94
The Role of Interleukin-6 in Castleman Disease
Yoshizaki, K., Murayama, S., Ito, H., & Koga, T. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.09.003 · Cited by 90
Hakovirta, H. H., Syed, V., Jégou, B., & Parvinen, M. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03475-m · Cited by 89
Kawai, M., Hagihara, K., Hirano, T., Shima, Y., Kuwahara, Y., Arimitsu, J., Narazaki, M., Ogata, A., Kawase, I., Kishimoto, T., et al. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken468 · Cited by 89
Interleukin 6 and expression of its receptor on epidermal keratinocytes
Yoshizaki, K., Nishimoto, N., Matsumoto, K., Tagoh, H., Taga, T., Deguchi, Y., Kuritani, T., Hirano, T., Hashimoto, K., Okada, N., et al. (1990) · Cytokine · doi:10.1016/1043-4666(90)90069-6 · Cited by 88
Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6.
Renauld, J., Vink, A., & SNICK, J. V. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.1894 · Cited by 86
Chung, S.-J., Kwon, Y.-J., Park, M., Park, Y., & Lee, S.-K. (2010) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.1.113 · Cited by 85
Boye, K., Grotterød, I., Aasheim, H., Hovig, E. J., & Mælandsmo, G. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23617 · Cited by 84
Macciò, A., & Madeddu, C. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1080-7 · Cited by 80
Fathi, M. A. A., El‐Hafeez, A. A. A., Abdelhamid, D. S., Abbas, S. H., Montano, M. M., & Abdel‐Aziz, M. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.11.032 · Cited by 80
IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.
Chiu, C., & Lee, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.1909 · Cited by 76
Hayashi, M., Kim, Y.-P., Takamatsu, S., Enomoto, A., SHINOSE, M., Takahashi, Y. I., Tanaka, H., Komiyama, K., & Ōmura, S. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1091 · Cited by 76
Synthesis of andrographolide derivatives and their TNF-α and IL-6 expression inhibitory activities
Li, J., Huang, W., Zhang, H., Wang, X., & Zhou, H. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.009 · Cited by 73
Lin, C.-M., Shyu, K., Wang, B.-W., Chang, H., Chen, Y., & Chiu, J. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf100421w · Cited by 69
Isolation and Structure of a 20,21-Epoxybufenolide Series from “Ch'an Su”
Kamano, Y., Nogawa, T., Yamashita, A., Hayashi, M., Inoue, M., Drašar, P., & Pettit, G. R. (2002) · Journal of Natural Products · doi:10.1021/np0200360 · Cited by 64
Apoptosis-Inducing Effects of Two Anthraquinones from Hedyotis diffusa WILLD.
Shi, Y., Wang, C.-H., & Gong, X. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1075 · Cited by 58
PTEN mutation: many birds with one stone in tumorigenesis.
Liu, W., Zhou, Y., Reske, S. N., & Shen, C. (2008) · PubMed · Cited by 54
Blockade of IL-6 Secretion Pathway by the Sesquiterpenoid Atractylenolide III
Kang, T., Han, N., Kim, H., & Jeong, H. (2011) · Journal of Natural Products · doi:10.1021/np100686a · Cited by 54
Singh, P., Kaur, S., Sharma, A., Kaur, G., & Bhatti, R. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.003 · Cited by 54
Self-citationXiang, R., Wang, Y., Zhang, N., Xu, W., Cao, Y., Tong, J., Li, J., Wu, Y., & Yan, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.188 · Cited by 52
Chaulet, C., Croix, C., Alagille, D., Normand, S., Delwail, A., Favot, L., Lecron, J., & Viaud‐Massuard, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.031 · Cited by 50
Interleukin-6 and C-Reactive Protein in Metastatic Renal Cell Carcinoma
Altundağ, Ö., Altundağ, K., & Gündüz, E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.155 · Cited by 49
Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
Wullschleger, A., Kapina, V., Molnarfi, N., Courvoisier, D. S., Seebach, J. D., Santiago‐Raber, M., Hochstrasser, D. F., & Lalive, P. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072399 · Cited by 48
Zhang, X., Zhang, J., Wei, H., & Tian, Z. (2007) · Oncology Reports · doi:10.3892/or.17.6.1377 · Cited by 46
Upadhyay, K. D., Bavishi, A., Thakrar, S., Radadiya, A., Vala, H., Parekh, S., Bhavsar, D., Savant, M. M., Parmar, M., Adlakha, P., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.016 · Cited by 45
Lee, S., Jang, H., Kim, Y., Oh, H., Lee, S., Jung, K., Kim, Y. H., Lee, W.-S., Lee, S.-W., & Rho, M. (2016) · Process Biochemistry · doi:10.1016/j.procbio.2016.09.003 · Cited by 45
The role of interleukin-6 in central nervous system demyelination
Petković, F., & Castellano, B. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.195273 · Cited by 42
Wang, X. H., Liu, B.-X., Qu, B., XING, H., Gao, S., Yin, J. M., Wang, X. F., & Cheng, Y. (2011) · Neoplasma · doi:10.4149/neo_2011_02_158 · Cited by 41
The Blockade of IL-6 Signaling in Rational Drug Design
Adachi, Y., Yoshio‐Hoshino, N., & Nishimoto, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246072 · Cited by 40
Binding of madindoline A to the extracellular domain of gp130.
Saleh, A. Z., Greenman, K. P., Billings, S. B., Vranken, D. V. V., & Krolewski, J. (2005) · Biochemistry · doi:10.1021/bi050439+ · Cited by 39
Sun, C., Yang, J., Cheng, H., Shen, W., Jiang, Z., Wu, M., Li, L., Li, W., Chen, T., Rao, X.-W., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152848 · Cited by 39
Pyrano-isochromanones as IL-6 Inhibitors: Synthesis, in Vitro and in Vivo Antiarthritic Activity
Jain, S. K., Singh, S., Khajuria, A., Guru, S. K., Joshi, P., Meena, S., Nadkarni, J. R., Singh, A., Bharate, S. S., Bhushan, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500901e · Cited by 38
Modeling Natural Anti-Inflammatory Compounds by Molecular Topology
Gálvez-Llompart, M., Zanni, R., & García‐Domenech, R. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129481 · Cited by 35
Lim, H. J., Jang, H. J., Bak, S. G., Lee, S.-Y., Lee, S. W., Lee, K. M., Lee, S., & Rho, M. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.053 · Cited by 34
Wu, X., Tian, F., Su, M.-H., Wu, M., Huang, Y., Hu, L., Jin, L., & Zhu, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.016 · Cited by 32
Furman, S., Nissim-Bardugo, E., Zeeli, S., Weitman, M., Nudelman, A., Finkin-Groner, E., Moradov, D., Shifrin, H., Schorer-Apelbaum, D., & Weinstock, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.081 · Cited by 31
Total synthesis of madindoline A
Hosokawa, S., Sekiguchi, K., Hayase, K., Hirukawa, Y., & Kobayashi, S. S. (2000) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)00939-4 · Cited by 29
Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6.
Ambrosino, D. M., Delaney, N. R., & Shamberger, R. C. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.4.1221 · Cited by 28
Lee, C., Lee, J. W., Jin, Q., Jang, H., Jang, H., Rho, M., Lee, M. K., Lee, C. K., Lee, M. K., & Hwang, B. Y. (2015) · Journal of Natural Products · doi:10.1021/np500803e · Cited by 28
Lai, C., Yang, G., Li, S., Lee, P., Wang, B., Chung, M.-C., Nagabhushanam, K., Ho, C., & Pan, M. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03712 · Cited by 28
Regulation of IL-6-type cytokine responses by MAPKs
Costa‐Pereira, A. P. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130267 · Cited by 27
Monanchosterols A and B, Bioactive Bicyclo[4.3.1]steroids from a Korean Sponge Monanchora sp.
Wang, W., Lee, T. G., Patil, R. S., Mun, B., Yang, I., Kim, H., Hahn, D., Won, D. H., Lee, J., Lee, Y., et al. (2014) · Journal of Natural Products · doi:10.1021/np500760v · Cited by 26
CD40 promotion of amyloid beta production occurs via the NF‐κB pathway
Ait‐Ghezala, G., Volmar, C., Frieling, J. S., Paris, D., Tweed, M., Bakshi, P., & MULLAN, M. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05424.x · Cited by 25
A novel small-molecule inhibitor of IL-6 signalling
Zinzalla, G., Haque, M. R., Basu, B. P., Anderson, J., Kaye, S. L., Haider, S. M., Hasan, F., Antonow, D., Essex, S., Rahman, K. M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.117 · Cited by 25
Synthesis of benzoxazole derivatives as interleukin-6 antagonists
Kim, D., Won, H. Y., Hwang, E. S., Kim, Y., & Choo, H. P. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.03.072 · Cited by 22
Design, synthesis, and biological activities of madindoline analogues.
Yamamoto, D., Sunazuka, T., Hirose, T., Kojima, N., Kaji, E., & Ōmura, S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.107 · Cited by 21
Singh, S., Gajulapati, V., Gajulapati, K., Goo, J.-I., Park, Y.-H., Jung, H. Y., Lee, S. Y., Choi, J. H., Kim, Y. K., Lee, K., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.016 · Cited by 21
Lotem, J., Shabo, Y., & Sachs, L. (1989) · PubMed · Cited by 19
Kumar, P., Singh, A. K., Raj, V., Rai, A., Maity, S., Rawat, A., Kumar, U., Kumar, D., Prakash, A., Guleria, A., et al. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0008 · Cited by 19
Singh, A. K., Bhadauria, A. S., Kumar, U., Raj, V., Maurya, V., Kumar, D., Maity, B., Prakash, A., De, A., Samanta, A., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.02.029 · Cited by 18
Li, C., Shoji, S., & BEEBE, J. S. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13641 · Cited by 16
Mishra, P., Raj, V., Bhadauria, A. S., Singh, A. K., Rai, A., Kumar, P., Keshari, A. K., De, A., Samanta, A., Kumar, U., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.009 · Cited by 14
Jung, Y. J., Kim, B. O., Kwak, J. H., & Pyo, S. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03407 · Cited by 12
Boos, T. L., Cheng, K., Greiner, E., Deschamps, J. R., Jacobson, A. E., & Rice, K. C. (2012) · Journal of Natural Products · doi:10.1021/np2008957 · Cited by 8
The systematic search for risk factors in multiple sclerosis
McKay, K. A., & Tremlett, H. L. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70015-3 · Cited by 7
Bandgar, B., Hote, B. S., Gangwal, R., & Sangamwar, A. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9856-1 · Cited by 7
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Cited by
Tocilizumab treatment in COVID‐19: A single center experience
Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25801 · Cited by 1,237
Humanized mouse models for immuno-oncology research
Chuprin, J., Buettner, H., Seedhom, M. O., Greiner, D. L., Keck, J. G., Ishikawa, F., Shultz, L. D., & Brehm, M. A. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00721-2 · Cited by 423
Campochiaro, C., Della-Torre, E., Cavalli, G., De Luca, G., Ripa, M., Boffini, N., Tomelleri, A., Baldissera, E., Rovere-Querini, P., Ruggeri, A., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.05.021 · Cited by 394
The complex role of adipokines in obesity, inflammation, and autoimmunity
Taylor, E. B. (2021) · Clinical Science · doi:10.1042/cs20200895 · Cited by 330
Interleukin-6 in Rheumatoid Arthritis
Pandolfi, F., Franza, L., Carusi, V., Altamura, S., Andriollo, G., & Nucera, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155238 · Cited by 278
Metadata
- Authors
- Kaur, S., Bansal, Y., Kumar, R., & Bansal, G.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 28
- Issue
- 5
- Pages
- 115327
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W3002457465
- Cited by
- 449
- References
- 146
- FWCI
- 19.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.